在2025年世界艾滋病日,天龙启动了一个新的血液筛查系统,以便非常准确地早期检测艾滋病毒、乙型乙型乙型乙型乙型乙型六氯环己烷和乙型乙型乙型乙型六氯环己烷感染。 On World AIDS Day 2025, Tianlong launched a new blood screening system to detect early HIV, HBV, and HCV infections with high accuracy.

在2025年世界艾滋病日,设在中国的诊断公司天龙引入了新的血液检查综合核酸检测系统,用于检测早期艾滋病毒-1、HIV-2、HBV和高敏感度和自动化的HCV感染。 On World AIDS Day 2025, China-based diagnostics company Tianlong introduced a new integrated nucleic acid testing system for blood screening, designed to detect early-stage HIV-1, HIV-2, HBV, and HCV infections with high sensitivity and automation. 解决方案旨在通过更早地确定低病毒-负载感染,降低疾病传播的风险,改善输血安全。 The solution aims to improve transfusion safety by identifying low-viral-load infections earlier, reducing the risk of disease transmission. 该公司也包括上海Kehua生物工程有限公司,提供分子、免疫诊断学和护理点的诊断仪器和试剂,供血液中心、临床实验室和公共卫生部门使用。 The company, which also includes Shanghai Kehua Bio-engineering Co., Ltd., provides diagnostic instruments and reagents across molecular, immunodiagnostic, and point-of-care platforms for use in blood centers, clinical labs, and public health sectors. 天龙的首席执行官强调了安全血液供应对全球公共健康的重要性。 Tianlong’s CEO emphasized the importance of safe blood supplies for global public health.